RNS-60

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NameRNS-60
Drug Alias NameOxygenated salineRNS-60
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor modulatorsHeat shock protein HSP90 modulators
TargetsG-protein coupled receptorHeat shock protein HSP90
Therapy Area/IndicationsIschemic StrokeDiabetes Mellitus, Type 2Myocardial Infarction +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRevalesio
China Registration ClassN/A

Develop Information

Active CompaniesRevalesio CorporationMario Negri Institute For Pharmacological Research
Inactive CompaniesUniversity Of Maryland, Baltimore
Active IndicationsIschemic StrokeAmyotrophic Lateral Sclerosis
Inactive IndicationsDiabetes Mellitus, Type 2Myocardial InfarctionMultiple Sclerosis, Relapsing-Remitting +[4] 

Other Information

ATC CodeN/A
Related LinksN/A